Skip to main content

and
  1. Article

    Open Access

    Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience

    Bone metastases (BM) are a serious cancer complication, potentially causing substantial morbidity. Among the clinical issues related to BM, there is the lack of specific tools for early diagnosis and prognosis...

    Stella D’Oronzo, Mauro Cives, Eleonora Lauricella in Clinical and Experimental Medicine (2024)

  2. Article

    Open Access

    Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma

    Stefania Stucci, Marco Tucci, Paolo Antonio Ascierto in Journal of Translational Medicine (2015)

  3. Article

    Open Access

    Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: a potential role as additional prognostic marker

    Stefania Stucci, Marco Tucci, Anna Passarelli in Journal of Translational Medicine (2015)